May 4, 2020
Kala re-applies Eysuvis to FDA for Dry Eye Disease
Kala Pharmaceuticals has resubmitted its New Drug Application to the FDA for Eysuvis, its product candidate to treat dry eye disease.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Kala Pharmaceuticals